Delivery Order W81K0219D0011-W81K0219F0292
Award Date 9/29/19
Potential Completion Date 10/31/20
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Medical Command awarded a $34,329.12 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services in support of the Brian D. Allgood Army Community Hospital and 121st Combat Support Hospital in Korea. The testing will be conducted under an Other Transaction for Prototype III agreement and is to be completed by September 28, 2023. Perkinelmer Genetics, Inc. is a subsidiary of Revvity Inc., which operates in the medical imaging...
- The Department of the Army Medical Command awarded a $37,989.49 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services at Brian D. Allgood Army Community Hospital/121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide these services from September 2020 through September 2021 in support of the hospital's newborn screening program. Perkinelmer Genetics is a subsidiary of Revvity Inc., which focuses on medical...
- The Department of the Army Medical Command awarded a $45,092.88 firm fixed price delivery order to Perkinelmer Genetics, Inc. of Pittsburgh, Pennsylvania for newborn screening testing services in support of Brian D. Allgood Army Community Hospital and the 121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide newborn screening to be performed at its laboratory in Pittsburgh on samples collected at the Army medical treatment facilities. The testing...
- This firm fixed price delivery order for $40,945.50 was awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea. The order is for the base period of September 29, 2024 through September 28, 2025. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., is a for-profit organization that specializes in medical imaging and genetic...
- This delivery order against the Defense Health Agency's Newborn Screening Testing Services contract awards Perkinelmer Genetics, Inc. $8,918.84 to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea from June 1, 2023 through September 28, 2023. As the prime contractor, Perkinelmer Genetics will perform the testing at its own facilities, with oversight from the Defense Health Agency. The contract has no set-aside designation and utilizes a...
- The Department of the Army Medical Command awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc. to provide newborn screening test kits. The contract, which has a potential value of $148,000.00, is for the delivery of newborn screening services to support military hospitals and treatment facilities in the U.S. and overseas, such as at Fort Bliss in Texas and at medical facilities in South Korea. Perkinelmer Genetics, a for-profit organization, also...
- The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
- The Defense Health Agency awarded Revvity Omics Inc., operating as Perkinelmer Genetics, a $42,993 delivery order for newborn screening testing services at Brian D. Allgood Army Community Hospital in South Korea. This firm fixed-price contract, awarded on September 29, 2025, is scheduled for completion by September 28, 2026, and operates under a larger single-award indefinite delivery contract vehicle valued at $301,668 with a performance period extending through September 2029. The delivery...
- The Department of the Army Medical Command has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to PerkinElmer Genetics, Inc., a for-profit organization, to provide newborn screening test kits. The contract, valued at $148,000.00, requires PerkinElmer Genetics to conduct testing for conditions such as glucose-6-phosphate dehydrogenase deficiency, galactosemia, congenital hypothyroidism, and hemoglobinopathies. The services will support military hospitals and treatment...
- This contract was awarded by the Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, and has a potential value of $150,000.00. The services under this contract include testing newborns for conditions such as glucose-6-phosphate dehydrogenase deficiency, galactosemia, congenital hypothyroidism, and hemoglobinopathies. These...